Ask to take part

Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.

Contact Information:

Dr Nadine Foster
-
n.foster@keele.ac.uk


Study Location:

Find another location


Questions to ask
Skip to Main Content
English | Cymraeg
Be Part of Research - Trial Details - Subacromial impingement syndrome and pain
Back

Subacromial impingement syndrome and pain

Not Recruiting

Open to: All Genders

Age: Adult

Newcastle

Medical Conditions

Topic: Primary Care Research Network for England, Musculoskeletal
Subtopic: Not Assigned, Musculoskeletal (all Subtopics)
Disease: Musculoskeletal, All Diseases

This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.


Subacromial impingement syndrome (SIS) is a condition that involves pain and weakness in the shoulder muscle. It is the most common cause of shoulder problems, affecting 1 in 3 adults. It is usually treated with a combination of exercises and medications including corticosteroids (which reduce inflammation (swelling)). Exercises meant to treat the SIS are usually standard for everyone and not customised for each patient and it would be interesting to see whether personalised exercises work better, and whether using ultrasound (a scan that uses soundwaves to create an image of the inside of the body on a screen) can improve the accuracy of corticosteroid injections. There is a lack of evidence on the impact of exercise and corticosteroid injection for treating SIS. The aim of this study is to find out if corticosteroid injections in combination with individualised exercise are the most effective treatment for SIS.

Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.  

The recruitment start and end dates are as follows:

08 Jun 2011 31 Mar 2014

Publications

2014 Protocol article in http://www.ncbi.nlm.nih.gov/pubmed/24625273 protocol2017 Other publications in http://www.ncbi.nlm.nih.gov/pubmed/28818450 development and delivery2021 Results article in https://pubmed.ncbi.nlm.nih.gov/32816787/ results (added 24/08/2020)2021 Results article in https://pubmed.ncbi.nlm.nih.gov/33410493/ cost-effectiveness results (added 08/01/2021)

Participants are randomly allocated to one of four treatment groups. Group one participants take part in an individualised exercise program run by a physiotherapist and receive corticosteroid injections guided by ultrasound. This involves using an ultrasound probe to show the area in question so that the injection can be given accurately. Group two participants receive an information sheet with advice about exercises and receive an injection guided by an ultrasound. Group three participants take part in an individualised exercise program run by a physiotherapist and have an injection which is not guided by ultrasound. Group four participants receive an information sheet with advice about exercises and their injection is unguided. Participants complete a number of questionnaires in order to assess their shoulder pain at the start of the study, 6 weeks, 6 months and 12 months after treatment.


Adults with a diagnosis of SIS

You can take part if:



You may not be able to take part if:


·1. Below 18 years old2. Those whose main complaint is due to neck problems, acromioclavicular pathology, or other primary shoulder disorders including adhesive capsulitis or full thickness cuff tear3. Potentially serious pathology (inflammatory arthritis, polymyalgia rheumatica, malignancy etc) or ipsilateral shoulder surgery/replacement4. Those already on a surgical waiting list for shoulder surgery5. Contraindications to local corticosteroid injection (known blood coagulation disorders, warfarin therapy)6. Participation in a shoulderfocused exercise programme or shoulder injection in the last month7. Inability to provide written informed consent, complete written questionnaires, or read instruction leaflets written in English


Below are the locations for where you can take part in the trial. Please note that not all sites may be open.

  • Primary Care Sciences Research Centre, Keele
    Newcastle
    ST5 5BG

Participants may experience pain relief or improvement to their shoulder symptoms. There are very few risks with steroid injections and participants will be given information on how to manage risks. Due to the exercise treatment, there is risk of temporary soreness in the shoulder.

Dr Nadine Foster
-
n.foster@keele.ac.uk



The study is sponsored by Keele University (UK) and funded by National Institute for Health Research (NIHR) (UK) - Central commissioning facility (CCF).



We'd like your feedback

Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.


Is this study information helpful?

What will you do next?
Read full details for Trial ID: ISRCTN42399123

Or CPMS 9731

Last updated 08 January 2021

This page is to help you find out about a research study and if you may be able to take part

You can print or share the study information with your GP/healthcare provider or contact the research team directly.   

Back to the top